The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury
Open accessAbstract
Traumatic brain injury (TBI) is a leading cause of death and disability in people younger than 45 and is a significant public health concern. In addition to primary mechanical damage to cells and tissue, TBI involves additional molecular mechanisms of injury, termed secondary injury, that continue to evolve over hours, days, weeks, and beyond. The trajectory of recovery after TBI is highly unpredictable and in many cases results in chronic cognitive and behavioral changes. Acutely after TBI, there is an unregulated release of glutamate that cannot be buffered or cleared effectively, resulting in damaging levels of glutamate in the extracellular space. This initial loss of glutamate homeostasis may initiate additional changes in glutamate regulation. The excitatory amino acid transporters (EAATs) are expressed on both neurons and glia and are the principal mechanism for maintaining extracellular glutamate levels. Diffusion of glutamate outside the synapse due to impaired uptake may lead to increased extrasynaptic glutamate signaling, secondary injury through activation of cell death pathways, and loss of fidelity and specificity of synaptic transmission. Coordination of glutamate release and uptake is critical to regulating synaptic strength, long-term potentiation and depression, and cognitive processes. In this review, we will discuss dysregulation of extracellular glutamate and glutamate uptake in the acute stage of TBI and how failure to resolve acute disruptions in glutamate homeostatic mechanisms may play a causal role in chronic cognitive symptoms after TBI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Secondary damage includes excitotoxicity (64), oxidative stress (65), and widespread neuroinflammation (63).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Hall, E. D., Sullivan, P. G., Gibson, T. R., Pavel, K. M., Thompson, B. M., & Scheff, S. W. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.252 · Cited by 319 · cited 2×
“widespread degradation to cortical, thalamic, and hippocampal brain regions, resulting in tissue loss, axonal shearing, and contusion.(21) A primary advantage of this model is the ease with which factors such as velocity and depth of injury can be controlled.”
BackgroundMethodA review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury
McConeghy, K. W., Hatton, J., Hughes, L., & Cook, A. M. (2012) · CNS Drugs · doi:10.2165/11634020-000000000-00000 · Cited by 158 · cited 2×
“competitive NMDA receptor antagonists, cannabinoid agonists, nitric oxide synthase inhibitors, AMPA antagonists, serotonin agonists, and magnesium sulfates.(114,115) While initially promising in phase II clinical trials, the synthetic cannabinoid receptor agonist”
BackgroundFloyd, C. L., Gorin, F. A., & Lyeth, B. G. (2005) · Glia · doi:10.1002/glia.20183 · Cited by 121
Self-citation
Research works printed but not linked: 119
- 10.1097/00001199-200609000-00001 · DOI
- 10.1046/j.1528-1157.44.s10.3.x · DOI · Paper page
- 10.1097/01.JTN.0000337149.29549.28 · DOI
- 10.1038/nrn3407 · DOI
- 10.1007/s00018-003-3319-x · DOI · Paper page
- 10.1089/neu.1993.10.215 · DOI
- 10.3171/jns.1990.73.6.0889 · DOI
- 10.1016/S1388-2457(03)00258-X · DOI
- 10.1111/j.1750-3639.2004.tb00056.x · DOI
- 10.1016/j.apmr.2013.08.297 · DOI
- 10.1016/j.apmr.2013.10.009 · DOI
- 10.1016/S0079-6123(08)60428-8 · DOI
- 10.1089/neu.2011.2261 · DOI
- 10.1038/nn791 · DOI
- 10.1080/15389588.2014.929670 · DOI
- 10.1089/089771504774129865 · DOI
- 10.1089/neu.2005.22.42 · DOI
- 10.1089/neu.2000.17.831 · DOI
- 10.1016/0306-4522(89)90247-9 · DOI
- 10.1602/neurorx.2.3.410 · DOI · Paper page
- 10.1089/neu.1994.11.587 · DOI
- 10.3171/foc.2007.22.5.2 · DOI
- 10.3389/fneur.2013.00059 · DOI
- 10.1016/0301-0082(95)00047-X · DOI
- 10.1016/S0301-0082(96)00012-3 · DOI
- 10.1523/JNEUROSCI.18-09-03158.1998 · DOI · Paper page
- 10.1126/science.289.5481.957 · DOI
- 10.1038/35025070 · DOI · Paper page
- Hollmann M., , Boulter J., , Maron C., , and Heinemann S. (1994). Molecular biology of glutamate receptors. Potentiation of N-methyl-D-aspartate receptor splice variants by zinc. Renal Physiol. Biochemist., 17, 182–183.
- 10.1146/annurev.ne.17.030194.000335 · DOI
- 10.1111/j.1749-6632.1999.tb11320.x · DOI
- 10.1016/S0074-7742(04)59002-5 · DOI
- 10.1016/S0959-4388(03)00008-4 · DOI
- 10.1126/stke.2002.156.re14 · DOI
- 10.1016/S0021-9258(18)82257-8 · DOI
- 10.1074/jbc.271.25.14883 · DOI
- 10.1016/S0301-0082(00)00067-8 · DOI · Paper page
- 10.1038/383634a0 · DOI
- 10.1523/JNEUROSCI.18-23-09620.1998 · DOI
- 10.1038/nrn2274 · DOI
- Kanai Y. (1997). Substrate binding sites of glutamate transporters and structurally related neutral amino acid transporters. Jpn. J. Physiol., 47 Suppl 1, S55–S56.
- 10.1523/JNEUROSCI.0790-07.2007 · DOI
- 10.1126/science.276.5319.1699 · DOI
- 10.1016/0306-4522(92)90316-T · DOI
- 10.1016/j.neuint.2007.06.005 · DOI
- 10.3389/fncel.2013.00038 · DOI
- 10.1016/j.neuron.2013.12.026 · DOI
- 10.1016/S0197-0186(00)00019-X · DOI
- 10.1111/j.1471-4159.2006.03743.x · DOI
- 10.1046/j.1471-4159.2001.00062.x · DOI
- 10.1074/jbc.M203771200 · DOI
- 10.1124/mi.4.1.48 · DOI
- 10.1016/j.neuint.2007.08.020 · DOI
- 10.1002/glia.22354 · DOI
- 10.1016/0896-6273(94)90057-4 · DOI
- 10.1002/cne.21823 · DOI
- 10.1523/JNEUROSCI.2777-11.2011 · DOI
- 10.1016/S1570-9639(02)00455-7 · DOI
- 10.1096/fj.08-107268 · DOI
- 10.1016/j.brainres.2004.03.023 · DOI
- 10.1016/S0896-6273(03)00800-6 · DOI
- 10.1016/j.neuroscience.2006.12.041 · DOI
- 10.1016/S0166-2236(97)01150-8 · DOI
- 10.1016/j.neuroscience.2007.07.063 · DOI
- 10.1007/PL00022038 · DOI
- Olney J.W. (1990). Excitotoxicity: an overview. Can. Dis. Wkly. Rep., 16 Suppl 1E, 47–57.
- 10.1097/00001756-199705260-00043 · DOI
- 10.1093/clinchem/47.8.1458 · DOI
- 10.1212/WNL.0000000000000105 · DOI
- 10.1126/science.2567056 · DOI · Paper page
- 10.1523/JNEUROSCI.19-18-08152.1999 · DOI
- 10.1007/978-1-61779-452-0_18 · DOI
- 10.1523/JNEUROSCI.0723-07.2007 · DOI
- 10.1002/glia.20312 · DOI
- 10.1007/s10522-013-9459-y · DOI
- 10.1113/jphysiol.1982.sp014152 · DOI
- 10.1016/S0143-4160(03)00141-6 · DOI
- 10.1523/JNEUROSCI.05-06-01483.1985 · DOI
- 10.1523/JNEUROSCI.07-02-00369.1987 · DOI
- 10.1523/JNEUROSCI.13-05-02085.1993 · DOI
- 10.1046/j.1460-9568.2001.01367.x · DOI
- 10.1016/S0896-6273(00)80086-0 · DOI · Paper page
- 10.1046/j.1471-4159.2000.0752252.x · DOI
- 10.1046/j.1471-4159.1998.70052020.x · DOI
- 10.1074/jbc.M600653200 · DOI
- 10.1002/glia.1082 · DOI
- 10.1089/neu.2012.2712 · DOI
- 10.1002/glia.20099 · DOI
- 10.1016/S0379-0738(02)00344-4 · DOI
- 10.1186/cc13814 · DOI
- 10.1016/j.brainres.2007.04.011 · DOI
- 10.1016/j.devbrainres.2004.06.019 · DOI
- 10.1016/j.neuroscience.2007.08.011 · DOI
- 10.1111/j.1460-9568.2005.04059.x · DOI
- 10.1016/S0896-6273(00)80997-6 · DOI
- 10.1016/j.brainres.2009.08.070 · DOI
- 10.1007/s004010050602 · DOI
- 10.1371/journal.pone.0069734 · DOI
- 10.1089/neu.2009.1237 · DOI
- 10.1089/neu.2011.2091 · DOI
- 10.3109/02699052.2013.794968 · DOI
- 10.1152/jn.00704.2012 · DOI
- 10.1016/0006-8993(95)00731-5 · DOI
- 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8 · DOI
- 10.1016/0006-8993(95)00179-T · DOI
- 10.1016/j.neulet.2009.04.064 · DOI
- 10.1002/ana.1230 · DOI
- 10.1016/S0006-8993(00)01986-7 · DOI
- 10.1523/JNEUROSCI.16-10-03189.1996 · DOI
- 10.1016/j.nbd.2004.12.011 · DOI
- 10.1517/13543784.10.4.753 · DOI
- 10.1016/S1474-4422(05)70253-2 · DOI
- 10.3171/jns.1999.91.5.0737 · DOI
- 10.1016/S1474-4422(06)70630-5 · DOI
- 10.1097/TA.0b013e31825133c0 · DOI
- 10.1111/jnc.13200 · DOI
- 10.1016/j.neuint.2011.12.001 · DOI
- 10.1186/1756-6606-6-6 · DOI · Paper page
- 10.1523/JNEUROSCI.4564-13.2014 · DOI
Cited by
Sorted by citations
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
Pál, B. Z. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2837-5 · Cited by 140
The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
Kokiko-Cochran, O. N., & Godbout, J. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00672 · Cited by 128
“Secondary damage includes excitotoxicity (64), oxidative stress (65), and widespread neuroinflammation (63).”
BackgroundYan, J., Zhang, Y., Wang, L., Zhao, L., Tang, S., Wang, Y., Gu, N., Sun, X., & Li, L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02651-3 · Cited by 146
“Secondary injury mainly includes: (1) excitotoxicity induced by excessive glutamate release [5], (2) free radical generation [6], and (3) neuroinflammatory response [7].”
Background
Metadata
- Authors
- Dorsett, C. R., McGuire, J. L., DePasquale, E. A. K., Gardner, A. E., Floyd, C. L., & McCullumsmith, R. E.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- University of Cincinnati (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- McCullumsmith, Robert E.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2017-01
- Volume
- 34
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- PMC
- PMC5220558
- OpenAlex
- W2494112084
- Cited by
- 163
- References
- 0
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 26 · 2023: 16 · 2022: 22 · 2021: 22 · 2020: 16 · 2019: 15 · 2018: 12 · 2017: 6
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neurotrauma (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institute of Mental Health (R01MH094445, R01MH107487)
- National Institute of Neurological Disorders and Stroke (R01NS075162)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- traumatic brain injury, glutamatergic neurotransmission, glutamate transporters, glutamate homeostasis, secondary injury, excitotoxicity, synaptic transmission, long-term potentiation and depression, rodent models
- MeSH terms
- Brain Injuries, Traumatic, Animals, Disease Models, Animal, Humans, Synaptic Transmission, Neuroglia, Rodentia, Synapses, Signal Transduction, Glutamic Acid, Glutamate Plasma Membrane Transport Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review